Bicycle Therapeutics' (BCYC) "Overweight" Rating Reiterated at Cantor Fitzgerald
Cantor Fitzgerald reiterated their overweight rating on shares of Bicycle Therapeutics (NASDAQ:BCYC – Get Rating) in a report issued on Friday morning, Zacks.com reports. Several other equities research analysts have also commented on the stock. Zacks Investment Research lowered shares of Bicycle Therapeutics from a buy rating to a hold rating in a research note […]